EGFR and non-small cell lung carcinoma: This analysis demonstrated that peripheral blood liquid biopsy had a good specificity for detecting EGFR mutation in NSCLC patients, while tissue biopsy still needs to be undertaken for negative blood biopsy patients due to its lower sensitivity [17].